Januvia is a medication prescribed to patients, suffering from Type 2 diabetes. It is offered in the form of mix pill (Janumet), containing metformin. Janumet and Januvia are said to enhance blood sugar control, but both drugs are associated with pancreatic cancer and acute pancreatitis.
The Historic Perspective
Januvia is a diabetes drug, which is produced by Merck & Co. This tablet hit the market with high level of expectations and the initial results showed a lot of positive signs. FDA had initially approved Januvia for sale, marketing and distribution in the US. The drug works by reducing the blood sugar level, which encourages the body system to generate insulin, resulting in getting proper balance, which is necessary between the amount of blood sugar and insulin that is present.
In the process, Januvia could lead to other risk factors in the patient’s body. Since Type 2 diabetes was the major point of concern in US for many years, there was huge demand for medication curing the condition and eventually, many firms manufactured and released drugs, including Januvia. Though it was used in high degree when it was released, it started impacting later on. Due to its severe negative side effects and potential risks, people started taking help from attorneys to file lawsuits soon enough.
On Sept 25, 2009, FDA issued a warning to Januvia, regarding its side effects, such as thyroid cancer and pancreatic cancer. If you’ve consumed this medication and are concerned about pancreatitis or pancreatic cancer, you should contact your lawyer about the possibility of filing a cancer lawsuit. Ever since FDA approved Januvia in 2006, it received many complaints related to acute pancreatitis and 2 cases of necrotizing or hemorrhagic pancreatitis until 2009. The agency reviewed patients and discovered that 21% of patients experienced problems within one month of Januvia consumption.
Changes Made to the Label and Instructions for Consumption
The agency asked the manufacturer to update its label, stating to include warning messages, such as details about post marketing statements of acute pancreatitis, necrotizing pancreatitis, hemorrhagic pancreatitis, and any other severe form. It was also suggested that healthcare organizations should monitor patients for the buildup of pancreatitis after dose increases of metformin or sitagliptin and to discontinue metformin or sitagliptin, if pancreatitis is believed while using these drugs. During this process, it was discovered that patients didn’t develop pancreatitis and FDA said that metformin/ sitagliptin can be used carefully and with right monitoring in patients with history of pancreatitis.
Potential Side Effects of Januvia
An in-depth study revealed that Januvia could lead to higher risk and lower-grade risk of pancreatic cancer and pancreatitis in some patients who use Januvia for longer period. As of now, law firms and attorneys are investigating and forming lawsuit against the manufacturer, claiming failure to warning labels, negligence, and product liability. The medicine has many side effects and majority of them are related to pancreatic cancer and acute pancreatitis and if you find any of these symptoms, you can speak to experienced, professional attorney, who may analyze your case at no obligation or no cost.
If you or anyone you know is suffering from pancreatic cancer or illness while consuming Type 2 diabetes drug (Januvia), you are entitled to medical reimbursement. For free case evaluation, you can contact 1800lawfirm.com januvia to determine the best course of action in your case.
Author Bio – This post has been contributed by Wilson Hedrick, who works for healthcare organization and knows all the nitty-gritty about the various drugs suitable for cancer patients, and potential side effects of various medicines.